alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
From: roesny@verizon.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 2:08:24 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Rose Snyder

Frostburg, MD 21532
CATERPILLAR FINANCIAL SERVICES CORPORATION

POWERNOTES (SM)

With Maturities of 9 months or more from Date of Issue

 

Registration No.  333-59540

Filed Pursuant to Rule 424 (b) (3)

PRICING SUPPLEMENT NO.  209				Trade Date: 08/15/02
(To Prospectus Supplement & Prospectus dated

  June 1, 2001)							Issue Date:  08/20/02
The Date of this Pricing Supplement August 16, 2002
SUBJECT TO REDEMPTION OR REPAYMENT

  CUSIP									Date and terms of redemption or

     or	Stated				             Interest			repayment (including any

Common	Interest		  Price to	 Discounts &         Payment	Survivors		applicable regular or special

  Code	Rate (1)	Maturity	Public (2)	Commissions       Frequency	  Option	Yes/No	record dates)

14911QJS1   3.15%	08/15/05	     100%	       0.65%                Quarterly	     YES	    NO	

Principal						1st Payment	Day	

Amount		Proceeds		Dealer		      Date		Count

$2,457,000.00	$2,441,092.50	ABN AMRO Inc.	   11/15/02		30/360	
 

Original Issue Discount Note:					Total Amount of OID:

____  Yes	  X   No						N/A

 

 
- The interest rates on the PowerNotes (SM) may be changed by Caterpillar Financial Services Corporation from time to time, but any such change will not affect the interest rate on any PowerNotes (SM) offered prior to the effective date of the change.   Prior to the date of this Pricing Supplement, $674.420 mm principal amount of the PowerNotes (SM) were sold at interest rates then in effect.  Subsequent offerings of PowerNotes (SM) will be made under a Prospectus Supplement and Prospectus dated June 1, 2001.
Additionally, the total principal amount of PowerNotes(SM) offered by Caterpillar Financial Services Corporation pursuant to its Prospectus Supplement and Prospectus dated June 1, 2001 has been increased from $500.0mm to $750.0mm.  $250.0mm principal amount of debt securities registered pursuant to Registration Statement No. 333-59540 originally offered by Caterpillar Financial Services Corporation pursuant to its Prospectus Supplement dated June 15, 2001 and related Prospectus dated May 25, 2001 are being offered as PowerNotes(SM) by Caterpillar Financial Services Corporation pursuant to its Prospectus Supplement and Prospectus dated June 1, 2001.
- Expressed as a percentage of aggregate principal amount.  Actual Price to Public may be less, and will be determined by prevailing market prices at the time of purchase as set forth in the confirmation sheet.
* Pursuant to 5TH CIR. R. 47.5, the court has determined

that this opinion should not be published and is not precedent

except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 02-41199

Conference Calendar

 

ANTHONY BONFANTI, JR.,

Petitioner-Appellant,

versus

JANIE COCKRELL, DIRECTOR, TEXAS DEPARTMENT 

OF CRIMINAL JUSTICE, INSTITUTIONAL DIVISION,

Respondent-Appellee.

--------------------

Appeal from the United States District Court

for the Southern District of Texas

USDC No. G-02-CV-499

--------------------

December 11, 2002

Before JOLLY, DAVIS, and JONES, Circuit Judges.

PER CURIAM:*

Anthony Bonfanti, Jr., Texas prisoner # 228024, was

convicted by a jury in 1978 of aggravated rape and was sentenced

to life imprisonment. He appeals the district court’s denial of

his 28 U.S.C. § 2254 petition, in which he alleged that he was

being denied his statutory and constitutional right to release on

mandatory supervision. The district court granted a certificate

of appealability (COA) on this issue.
No. 02-41199

-2-

Bonfanti contends that he has a statutory and constitutional

expectation of release on mandatory supervision; that he has such

expectation that his earned and good-conduct time would be

calculated to determine his release date; and that Ex parte

Franks, 71 S.W.3d 327, 328 (Tex. Crim. App. 2001), ignored the

intent of the relevant statute and renders that statute

unconstitutionally vague. Bonfanti’s arguments are foreclosed

by this court’s decision in Arnold v. Cockrell, 306 F.3d 277

(5th Cir. 2002).

AFFIRMED.
From: p_roslansky@yahoo.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:33:22 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Paula Roslansky

Hinton, IA 51024
Q Lotus Holdings, Inc.

    

    A Financial Services Company 	 	Chicago, IL 60654

    

    (312) 379-1800 



 


 













 


 


 


		From:	Marckensie Theresias



475 Brickell Ave #3713


Miami, FL 33131


 


		To:	Q Lotus Holdings, Inc.



520 N Kingsbury St, Unit 1810


Chicago, IL 60654


		Attn:	Gary Rosenberg



 


 


		Re:	Resignation



 


 


Dear Mr. Rosenberg,


 


Please accept this formal letter as my official notice to resign
my positions as Chairman and a member of the Board of Directors of Q Lotus Holdings, Inc.


 


Please accept this resignation effective as of this 17th
day of December, 2012.


 


I am resigning for personal reasons and remain committed to
the company, and stand ready to help if called upon.


 


Sincerely,


 


/S/ Marckensie Theresias


Marckensie Theresias
1 

### Daniels, Nia (FAA)

From: Daniels, Nia (FAA)

Sent: Thursday, April 02, 2015 2:37 PM

To: 'marc@mlabs.co'

Cc: '333exemptions@faa.gov' Subject: Petition for Exemption: Voler, Inc. FAA-2014



### April 2, 2015

Mr. Marc Asselin

Founder and President Voler, Inc. 3825 Majestic Palm Way Delray Beach, FL 33445

Dear Mr. Asselin:

This letter is to inform you that the following information is missing from your petition (Docket No. FAA2014-1106). This information is necessary for the Fe deral Aviation Administration (FAA) to process your petition.

 Describe the aircraft make, mode l, and type(i.e. - fixed-wing, roto rcraft, lighter-than-air) for the proposed UAS operation. The description(s) sh ould include the maximum weight (including payload). This information can be located in the aircraft manual(s).

Please submit the additional information (non-proprietary) to your docket at www.regulations.gov and submit any proprietary information to the FAA Hea dquarters or electronically via e-mail to 333exemptions@faa.gov . If you want us to process your request a ny further, we must receive the information described above by April 16, 2015. If we do not receive the information, we will close the docket without notifying you further.

If you have any questions, please feel free to contact me at (202) 267-9677.

Sincerely,

Nia Daniels, ARM

‐ 108

Federal Aviation Administration

Office of Rulemaking, Airmen & Airspace Rules Division

800 Independence Avenue, SW Washington, DC 20591

PH: (202) 267 ‐ 7626

Fax: (202) 267 ‐ 5075 nia.daniels@faa.gov
NMbLMo JS9i

~t

LEGAL GUIDANCE

REIMPORTATION_ OF PHARMACEUTICALS

The Food and Drug Administration (FDA),
settling an issue stemming from federal
legislation passed four years ago, has
given the Armed Services a green light to
return surplus pharmaceutical items from
bases located in foreign countries to the
United States for further military use.

Congress, in 1987, enacted the Prescrip-
tion Drug Marketing Act (Public Law 100-
293). In pertinent part, this law amended
section 801 of the Food, Drug and Cosmetic
Act to prohibit the reimportation of
U.S.-produced pharmaceuticals except by
the original manufacturer of the product
or as authorized by the Secretary of Health
and Human Services for emergency purposes.
This reimportation ban was intended to
prevent foreign counterfeit drugs, falsely
described as reimported U.S.-produced
items, from entering the pharmaceutical
distribution system. In addition, con-
gress found that proper storage and han-
dling of legitimate prescription drugs
cannot be guaranteed by U.S. law once the
pharmaceuticals have left the boundaries
ef the United States. The FDA has the
responsibility of enforcing this ban.

Since its inception, the scope of the
reimportation ban has not been entirely
clear. The title of the law and the
purposes behind it suggested that it should
apply only to cases involving the marketing
or commercial trading of prescription
drugs. However, the language actually
used by Congress is reasonably open to a
broader interpretation and, if adopted,
would prohibit most transfers or shipments
of U.S.-made items from a foreign country
to the United States.

At the conclusion of hostilities in the
Persian Gulf, deployed Naval medical units
retained on hand large quantities of unused
pharmaceuticals for which the United
States was the country of origin. Due
to the uncertainty as to the scope of the
reimportation ban imposed by the Prescrip-
tion Drug Marketing Act, it was originally

feared that this law might require the Navy
to leave these medical products in the
theatre of operations. This would have
been a costly result since these drugs
would not then be available to supplement
the pharmaceutical inventories of the
Navy's stateside hospitals and clinics and
replacement purchases would be necessary.
Fortunately, in response to a request by
the Naval Medical Logistics Command for an
advisory opinion, the FDA has determined
that the Prescription Drug Marketing Act
does not present a bar to the return of
surplus prescription drugs from overseas
military bases where they were stocked in
support of OPERATION DESERT STORM.

NMLC point of contact is Mr. Robert Osing
who may be reached at (301) 663-2157 or by
DSN at 343-2157.
From: Jn-3-16@verizon.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:55:30 PM

To Whom It May Concern:

I am writing today to ask that you rescind the unjust and coercive mandate that all "contraceptives" and

sterilization procedures be covered by private health insurance with no co-pay to patients. On the other

hand, if you do not reverse course I ask you to have conscience protections for any organizations that

provide individual and group insurance, especially for those having moral or religious objections. I

strongly oppose the government mandating free insurance coverage on Americans, especially for any

drugs or device that that can cause the equivilent of an abortion.

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization or business, that has moral or religious objections in providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws, that

prohibit government discrimination against those who object to such health services on the basis of

moral or religious grounds.

The definition of a "religious employer," in this regulation is so narrow, it only includes churches.

However, a host of businesses and organizations that have conscience objections will still be required to

support it. This is supposed to be a free country, one with free choice, not one where employers are

forced to choose between either violating their conscience, or not being able to offer employees health

insurance.

Please, let the law continue to protect the conscience rights of insurers, providers and people like me

who object to being forced against our will by the federal government. Our concience is violated if

forced to offer or subsidize contraceptives and sterilization services, especially when some of these

drugs can take the life of early unborn children. No Americans should be forced by federal government

to subsidize services they object to. Again I urge you in the strongest way possible to reconsider and

remove contraceptives and sterilizations from the list of mandatory preventive services.

Sincerely,

Donald McFarren

Metuchen, NJ 08840
No. 184, Misc.

#### Collins *v.*Louisiana.

Supreme Court of Louisiana. Certiorari denied.
<PAGE>



                                                                    EXHIBIT 32.1



 CERTIFICATION OF PRESIDENT AND CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.
            SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of Cover-All Technologies Inc., a Delaware
corporation (the "Company"), on Form 10-K for the period ended December 31, 2006
as filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, John W. Roblin, President and Chief Executive Officer (principal
executive officer) of the Company, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to
my knowledge:

        (1) the Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

        (2) the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Date:    April 2, 2007

/s/ John W. Roblin
----------------------------------------------
Name:    John W. Roblin
Title:   President and Chief Executive Officer
IV 

110TH CONGRESS 

2D SESSION H. RES. 1377 

Recognizing the commencement of Ramadan, the Islamic holy month of fasting and spiritual renewal, and commending Muslims in the United States 

and throughout the world for their faith. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 24, 2008 

Ms. EDDIE BERNICE JOHNSON of Texas submitted the following resolution; 

which was referred to the Committee on Foreign Affairs 

RESOLUTION 

Recognizing the commencement of Ramadan, the Islamic 

holy month of fasting and spiritual renewal, and commending Muslims in the United States and throughout 

the world for their faith. 

Whereas since the terrorist attacks on the United States on 

September 11, 2001, threats and incidents of violence 

have been directed at law-abiding, patriotic Americans of 

African, Arab, and South Asian descent, particularly 

members of the Islamic faith; 

Whereas, on September 14, 2001, the House of Representatives passed a concurrent resolution condemning bigotry 

and violence against Arab-Americans, American Muslims, 

and Americans from South Asia in the wake of the terrorist attacks; 


wwoods2 on PRODPC68 with BILLS
2 

•HRES 1377 IH 

Whereas it is estimated that there are approximately 

1,500,000,000 Muslims worldwide; 

Whereas nearly 6,000 Muslims serve as members of our 

Armed Forces; 

Whereas Ramadan is the holy month of fasting and spiritual 

renewal for Muslims worldwide, and is the 9th month of 

the Muslim calendar year; and 

Whereas the observance of the Islamic holy month of Ramadan commences at dusk on September 1, 2008, and continues for one lunar month: Now, therefore, be it 

1 Resolved, That— 

2 (1) during this time of conflict, in order to 

3 demonstrate solidarity with and support for mem4 bers of the community of Islam in the United States 

5 and throughout the world, the House of Representa6 tives recognizes the Islamic faith as one of the great 

7 religions of the world; and 

8 (2) in observance of and out of respect for the 

9 commencement of Ramadan, the Islamic holy month 

10 of fasting and spiritual renewal, the House of Rep11 resentatives acknowledges the onset of Ramadan and 

12 expresses its deepest respect to Muslims in the 

13 United States and throughout the world on this sig14 nificant occasion. 

Æ 


wwoods2 on PRODPC68 with BILLS
EXHIBIT
 32(b)



CERTIFICATION
 OFCHIEF FINANCIAL OFFICER

PURSUANT
 TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In
 connection with the report on Form 10-Q ofWWA
 Group, Inc. for thequarterly
 period endedJune 30,
 2009 as filed with the Securities and Exchange
 Commission on the date hereof, I,Digamber Naswa, do
 hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the
 best of my knowledge and belief:

| | (3) | Thisreport fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------

| | (4) | The information contained in this report fairlypresents, in all material respects, the financial condition of the registrant at the end of the period covered by this report and results of operations of
the registrant for the period covered by this report.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



Date:August
 19, 2009





/s/
 Digamber Naswa

Digamber
 Naswa

Chief
 Financial Officer



Thiscertification
 accompanies this report pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not,
 except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the
 registrant for the purposes of §18 of the Securities Exchange Act of 1934, as amended.
 This certification shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the
 Securities Exchange Act of 1934, as amended (whether made before or after the date of this report),
 irrespective of any general incorporation language contained in such filing.   A signed original of this written
 statement required by §906 has been provided to the registrant
 and will be retained by the registrant
 and furnished to the Securities and Exchange Commission or its staff upon request.
EXHIBIT 32

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED

PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Each of the undersigned hereby certifies, for the purposes of section 1350
of chapter 63 of title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of UCI Medical Affiliates, Inc. (UCI), that, to his knowledge, the Amendment
No. 1 to the Annual Report of UCI on Form 10-K for the period ended September 30, 2010, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report
fairly presents, in all material respects, the financial condition and results of operation of UCI. This written statement is being furnished to the Securities and Exchange Commission as an exhibit to such Form 10-K/A. A signed original of this
statement has been provided to UCI and will be retained by UCI and furnished to the Securities and Exchange Commission or its staff upon request.



|                       |  |  |  |                                                     
|---------------------- |  |  |  | ----------------------------------------------------
|Date: January 28, 2011 |  |  |  | /s/ D. Michael Stout, M.D.                          
|                       |  |  |  | D. Michael Stout, M.D.                              
|                       |  |  |  | President and Chief Executive Officer               
|                       |  | 
|                       |  |  |  | /s/ Joseph A. Boyle, CPA                            
|                       |  |  |  | Joseph A. Boyle, CPA                                
|                       |  |  |  | Executive Vice President and Chief Financial Officer